Randomized clinical trial on the efficacy of intranasal or oral ketamine-midazolam combinations compared to oral midazolam for outpatient pediatric sedation.
Joji Sado-FilhoKarolline Alves VianaPatrícia Corrêa-FariaLuciane Ribeiro de Rezende Sucasas da CostaPaulo Sucasas CostaPublished in: PloS one (2019)
ClinicalTrials.gov, identifier: NCT02447289. Registered on 11 May 2015, named "Midazolam and Ketamine Effect Administered Through the Nose for Sedation of Children for Dental Treatment (NASO)."